Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Merck
Boehringer Ingelheim
Moodys
AstraZeneca

Last Updated: November 30, 2021

DrugPatentWatch Database Preview

Patent Applications for imatinib mesylate


Email this page to a colleague

« Back to Dashboard

US Patent Applications for imatinib mesylate

US Patent Application Patent No. Title Patent Filing Date Patent Application Status Status Updated
⤷  Free Forever Trial ⤷  Free Forever Trial MANNICH BASE PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2001-05-24 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2008-04-21
⤷  Free Forever Trial ⤷  Free Forever Trial 1-(PYRRLOLIDIN-1-YLMETHYL)-3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2001-05-24 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-10-18
⤷  Free Forever Trial ⤷  Free Forever Trial PRODRUGS OF 3-(PYRROL-2-YLMETHYLIDENE)-2-INDOLINONE DERIVATIVES 2001-05-24 Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362 2010-12-20
⤷  Free Forever Trial ⤷  Free Forever Trial Effects of combined administration of farnesyl transferase inhibitors and signal transduction inhibitors 2001-10-04 Abandoned -- Failure to Respond to an Office Action 2004-09-10
⤷  Free Forever Trial ⤷  Free Forever Trial CRYSTAL MODIFICATION OF A N-PHENYL-2-PYRIMIDINEAMINE DERIVATIVE, PROCESSES FOR ITS MANUFACTURE AND ITS USE 2001-11-16 Patented Case 2006-11-29
⤷  Free Forever Trial ⤷  Free Forever Trial Methods and compositions for enhancing pharmaceutical treatments 2002-03-20 Abandoned -- Failure to Respond to an Office Action 2007-02-16
>US Patent Application >Patent No. >Title >Patent Filing Date >Patent Application Status >Status Updated

WIPO Patent Applications for imatinib mesylate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
McKesson
Dow
Johnson and Johnson
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.